Rheumatoid Arthritis Posts on Medivizor
Navigation Menu

Rheumatoid Arthritis Posts on Medivizor

Can light-intensity exercise reduce cardiovascular risk in patients with rheumatoid arthritis?

Posted by on Apr 25, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined the role of physical activity in rheumatoid arthritis (RA). The authors concluded that patients with RA are mostly active at light intensities. Light physical activity was found to reduce cardiovascular risk and also improved RA outcomes.  Some background Patients with rheumatoid arthritis (RA) can experience...

Read More

Biological drug treatments for rheumatoid arthritis – an update

Posted by on Apr 16, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined data from a number of recent studies to assess biological drug treatment for rheumatoid arthritis (RA). The authors concluded that the results confirmed the effectiveness of biological drugs in treating RA. Some background Disease-modifying anti-rheumatic drugs (DMARDs) is a category of drugs defined by their use...

Read More

Anti-TNF therapy: Predictors of success

Posted by on Mar 15, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell The study examined predictors of treatment success with anti-TNF drugs for rheumatoid arthritis (RA). The authors concluded that immune response and the presence of a protein in the blood can predict treatment outcomes with anti-TNF drugs. Some background In rheumatoid arthritis (RA), the immune system attacks the healthy joints the...

Read More

Examining the presence of RA in patients with and without the presence of certain antibodies in the blood

Posted by on Mar 14, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study compared the severity of inflammation in rheumatoid arthritis (RA) patients with (seropositive) and without (seronegative) certain antibodies in their blood. The authors concluded that seronegative patients had higher levels of inflammation than seropositive patients. Some background RA is diagnosed based on a number of...

Read More

What is next for RA patients who have not responded to conventional treatment?

Posted by on Feb 8, 2017 in Rheumatoid Arthritis | 0 comments

In a nutshell This study compared the effectiveness of two different treatments in rheumatoid arthritis (RA) patients who have not responded well to conventional treatment with disease-modifying anti-rheumatic drugs (DMARDs). The authors concluded that changing to a biological drug showed better remission rates than switching to an alternative...

Read More

Do additional medical conditions increase the risk of mortality in patients with RA?

Posted by on Dec 18, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study looked at the link between additional medical conditions and mortality in patients with rheumatoid arthritis (RA). The authors identified a number of specific conditions that significantly increased mortality risk in RA patients. Some background Patients with rheumatoid arthritis (RA) have an increased risk of mortality...

Read More

Examining the link between rituximab treatment, immune cell response and disease activity?

Posted by on Dec 7, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study looked at the effect of rituximab (Rituxan) and levels of immune cells in patients with rheumatoid arthritis (RA).The authors concluded that certain immune cells are linked to disease activity in patients treated with rituximab. Measuring the levels of these cells could be used to determine if rituximab re-treatment is...

Read More